Chunrong Yu

3.6k total citations
49 papers, 3.0k citations indexed

About

Chunrong Yu is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Chunrong Yu has authored 49 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 13 papers in Oncology and 8 papers in Hematology. Recurrent topics in Chunrong Yu's work include Cell death mechanisms and regulation (13 papers), Histone Deacetylase Inhibitors Research (11 papers) and Cancer-related Molecular Pathways (9 papers). Chunrong Yu is often cited by papers focused on Cell death mechanisms and regulation (13 papers), Histone Deacetylase Inhibitors Research (11 papers) and Cancer-related Molecular Pathways (9 papers). Chunrong Yu collaborates with scholars based in United States, China and United Kingdom. Chunrong Yu's co-authors include Steven Grant, Paul Dent, Mohamed Rahmani, Alex A. Adjei, Geoffrey W. Krystal, Daniel H. Conrad, Mark A. Subler, Scott H. Kaufmann, Lewis R. Roberts and Bret B. Friday and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Chunrong Yu

48 papers receiving 3.0k citations

Peers

Countries citing papers authored by Chunrong Yu

Since Specialization

Citations

This map shows the geographic impact of Chunrong Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunrong Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunrong Yu more than expected).

Fields of papers citing papers by Chunrong Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunrong Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunrong Yu. The network helps show where Chunrong Yu may publish in the future.

Co-authorship network of co-authors of Chunrong Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Chunrong Yu. A scholar is included among the top collaborators of Chunrong Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunrong Yu. Chunrong Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tetrandrine is a potent cell autophagy agonist via activated intracellular reactive oxygen species 2015 ·Cell & Bioscience ·Haiqing Wang, Ting Liu, (unknown), Qin Wang, Chunrong Yu, Xin Liu, Wenhua Li	44
2	Schisandrin B protects PC12 cells against oxidative stress of neurodegenerative diseases 2015 ·Neuroreport ·(unknown), He Li, Chunrong Yu, Chunyan Yu, Shu Jing, Hongxia Sun, Chunmei Wang, (unknown), Jianguang Chen, Sen Wang	30
3	CBP Loss Cooperates with PTEN Haploinsufficiency to Drive Prostate Cancer: Implications for Epigenetic Therapy 2014 ·Cancer Research ·Liya Ding, Daiwen Chen, Ping Liu, Yunqian Pan, Jian Zhong, Kevin M. Regan, Liguo Wang, Chunrong Yu, Anthony E. Rizzardi, Liang Cheng, (unknown), Stephen C. Schmechel, John C. Cheville, Jan van Deursen, Donald J. Tindall, Haojie Huang	35
4	Apigenin Sensitizes Colon Cancer Cells to Antitumor Activity of ABT-263 2013 ·Molecular Cancer Therapeutics ·Huanjie Shao, Kai Jing, (unknown), Haihong Huang, Xianjun Fang, Chunrong Yu	82
5	Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo 2011 ·Journal of Hepatology ·Huanjie Shao, Chun Gao, Haikuo Tang, Hao Zhang, Lewis R. Roberts, Bonnie L. Hylander, Elizabeth A. Repasky, Wen Wang, Jingxin Qiu, Alex A. Adjei, Grace K. Dy, Chunrong Yu	41
6	Inhibition of mTOR Kinase by AZD8055 Can Antagonize Chemotherapy-induced Cell Death through Autophagy Induction and Down-regulation of p62/Sequestosome 1 2011 ·Journal of Biological Chemistry ·Shengbing Huang, Zhineng J. Yang, Chunrong Yu, Frank A. Sinicrope	68
7	Mcl-1 downregulation by YM155 contributes to its synergistic anti-tumor activities with ABT-263 2011 ·Biochemical Pharmacology ·Haikuo Tang, Huanjie Shao, Chunrong Yu, Jinsong Hou	56
8	Improved Response to nab-Paclitaxel Compared with Cremophor-Solubilized Paclitaxel is Independent of Secreted Protein Acidic and Rich in Cysteine Expression in Non-Small Cell Lung Cancer 2011 ·Journal of Thoracic Oncology ·Huanjie Shao, Haikuo Tang, Oreste E. Salavaggione, Chunrong Yu, Bonnie L. Hylander, Wei Tan, Elizabeth Repasky, Alex A. Adjei, Grace K. Dy	27
9	Sulfatase 2 protects hepatocellular carcinoma cells against apoptosis induced by the PI3K inhibitor LY294002 and ERK and JNK kinase inhibitors 2010 ·Liver International ·Jin-Ping Lai, Dalbir S. Sandhu, Chunrong Yu, Catherine D. Moser, Chunling Hu, Abdirashid M. Shire, Ileana Aderca, Linda M. Murphy, Alex A. Adjei, Schuyler O. Sanderson, Lewis R. Roberts	26
10	The Oncogenic Effect of Sulfatase 2 in Human Hepatocellular Carcinoma Is Mediated in Part by Glypican 3–Dependent Wnt Activation 2010 ·Hepatology ·(unknown), Abdul M. Oseini, Catherine D. Moser, Chunrong Yu, Sherine F. Elsawa, Chunling Hu, Ikuo Nakamura, Tao Han, Ileana Aderca, Hajime Isomoto, Megan Garrity-Park, Abdirashid M. Shire, Jia Li, Schuyler O. Sanderson, Alex A. Adjei, Martín E. Fernández-Zapico, Lewis R. Roberts	93
11	Sulfatase 2 up‐regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma† 2008 ·Hepatology ·Jinping Lai, Dalbir S. Sandhu, Chunrong Yu, Tao Han, Catherine D. Moser, (unknown), Rubén Bonilla Guerrero, Ileana Aderca, Hajime Isomoto, Megan Garrity-Park, Hongzhi Zou, Abdirashid M. Shire, David M. Nagorney, Schuyler O. Sanderson, Alex A. Adjei, Ju‐Seog Lee, Snorri S. Thorgeirsson, Lewis R. Roberts	168
12	MCL-1 as a Buffer for Proapoptotic BCL-2 Family Members during TRAIL-induced Apoptosis 2007 ·Journal of Biological Chemistry ·Xue Meng, Sun Hee Lee, Haiming Dai, David A. Loegering, Chunrong Yu, Karen S. Flatten, Paula A. Schneider, Nga T. Dai, Shaji Kumar, B. Douglas Smith, Judith E. Karp, Alex A. Adjei, Scott H. Kaufmann	97
13	The role of Mcl-1 downregulation in the proapoptotic activity of the multikinase inhibitor BAY 43-9006 2005 ·Oncogene ·Chunrong Yu, Laura M. Bruzek, Xue Meng, Gregory J. Gores, Christopher A. Carter, Scott H. Kaufmann, Alex A. Adjei	228
14	Evidence of a Functional Role for p21/ Down-Regulation in Synergistic Antileukemic Interactions between the Histone Deacetylase Inhibitor Sodium Butyrate and Flavopiridol 2004 ·Molecular Pharmacology ·Roberto R. Rosato, Jorge A. Almenara, Chunrong Yu, Steven Grant	61
15	The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib 2004 ·Experimental Cell Research ·Chunrong Yu, Mohamed Rahmani, Paul Dent, Steven Grant	119
16	Induction of Apoptosis in BCR/ABL+ Cells By Histone Deacetylase Inhibitors Involves Reciprocal Effects on the RAF/MEK/ERK and JNK Pathways 2003 ·Cancer Biology & Therapy ·Chunrong Yu, Mark A. Subler, Mohamed Rahmani, (unknown), Geoffrey W. Krystal, Daniel H. Conrad, Paul Dent, Steven Grant	59
17	Inhibition of PI-3 kinase sensitizes human leukemic cells to histone deacetylase inhibitor-mediated apoptosis through p44/42 MAP kinase inactivation and abrogation of p21CIP1/WAF1 induction rather than AKT inhibition 2003 ·Oncogene ·Mohamed Rahmani, Chunrong Yu, (unknown), Wesam Ahmed, Karen G. Hirsch, Paul Dent, Steven Grant	82
18	Induction of apoptosis in human leukemia cells by the tyrosine kinase inhibitor adaphostin proceeds through a RAF-1/MEK/ERK- and AKT-dependent process 2003 ·Oncogene ·Chunrong Yu, Mohamed Rahmani, Jorge A. Almenara, Edward A. Sausville, Paul Dent, Steven Grant	60
19	Coadministration of UCN-01 with MEK1/2 Inhibitors Potently Induces Apoptosis in 2002 ·Cancer Biology & Therapy ·Chunrong Yu, Yun Dai, Paul Dent, Steven Grant	19
20	MEK1/2 Inhibitors Promote Ara-C-Induced Apoptosis but Not Loss of ΔΨm in HL-60 Cells 2001 ·Biochemical and Biophysical Research Communications ·Chunrong Yu, Zhiliang Wang, Paul Dent, Steven Grant	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact